Forward Citations = 2

Loading Chart...

3 inventors (with patents filed for the assignee):

Thomas E Ichim (3 out of 51 patents)

Vladimir Bogin (2 out of 2 patents)

Neil Riordan (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 10869916 - Therapeutic immune modulation by stem cell secreted exosomes (2020-12-22),

2. 9433646 - Methods of inhibiting growth of a neoplastic cell (2016-09-06),

3. 9427450 - Therapeutic immune modulation by stem cell secreted exosomes (2016-08-30),

4. 8895299 - Method for expansion of stem cells (2014-11-25),

Xon Cells, Inc. is a leading biotechnology company focused on developing innovative cell therapies for cancer treatment. Founded in 2010, the company utilizes cutting-edge technology to engineer immune cells to target and destroy cancer cells. With a dedicated team of scientists and researchers, Xon Cells is committed to revolutionizing the way cancer is treated and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#34 in Germantown, MD

#872 in Maryland

#59,059 in US

Germantown, MD, United States of America

Xon Cells, Inc.

Forward Citations = 2

3 inventors:

Thomas E Ichim (3 out of 51 patents)

Vladimir Bogin (2 out of 2 patents)

Neil Riordan (1 out of 2 patents)

Please report any incorrect information to support@idiyas.com